Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05382754 · ClinicalTrials.gov registry record · NA

Home Apnea Testing in CHildren Trial

A NA study of Sleep Disturbance and Sleep Apnea, Obstructive, sponsored by Children's Hospital of Philadelphia.

Recruiting
Registry status
NA
Development phase
317
Enrollment target
1
Study location

NCT05382754 is a NA study of Sleep Disturbance and Sleep Apnea, Obstructive that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 317 participants, above the 172-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (84% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05382754, a NA study of Sleep Disturbance and Sleep Apnea, Obstructive, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.

RECRUITING
Registry status
NA
Development phase
317 participants
Enrollment target
1
Study location

Study Summary

This clinical trial will compare home sleep apnea testing with the gold standard in-lab polysomnography in terms of 1) accuracy, 2) therapeutic decision-making, and 3) parent/child acceptability in children referred for evaluation of obstructive sleep apnea.

Interventions

  • DIAGNOSTIC_TEST Home sleep apnea test
  • DIAGNOSTIC_TEST In-lab polysomnography

Study Locations (1)

Pennsylvania

  • The Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 317 participants
Start Date 2023-03-29
Est. Completion 2027-07
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT05382754

The ClinicalTrials.gov registry entry for NCT05382754 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 317 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 172-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (84% higher). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Sleep Disturbance appearing as the primary indexed condition, and to 2 interventions - of which Home sleep apnea test is the first listed.

NCT05382754 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05382754 about?

NCT05382754 is a clinical study titled "Home Apnea Testing in CHildren Trial". This clinical trial will compare home sleep apnea testing with the gold standard in-lab polysomnography in terms of 1) accuracy, 2) therapeutic decision-making, and 3) parent/child acceptability in children referred for evaluation of obstructive sleep apnea.

What is the current status of trial NCT05382754?

This trial is currently recruiting. It is a NA study. The enrollment target is 317 participants. The study started on 2023-03-29. Estimated completion is 2027-07.

What conditions does trial NCT05382754 study?

This clinical trial studies the following conditions: Sleep Disturbance, Sleep Apnea, Obstructive, Sleep Disorder, Sleep Apnea Syndromes.

What interventions are being tested in trial NCT05382754?

The interventions under investigation include: Home sleep apnea test (DIAGNOSTIC_TEST), In-lab polysomnography (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05382754?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05382754 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Disturbance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.